Stock Analysis

All Ring Tech And 2 Other Undiscovered Gems On None Exchange

Published

In a week marked by busy earnings reports and economic data, major global indices faced downward pressure, with small-cap stocks showing resilience compared to their large-cap counterparts. Amidst cautious market sentiment and mixed economic signals, the search for undiscovered gems becomes even more crucial as investors look for opportunities that can withstand volatility and offer potential growth. Identifying promising stocks often involves looking beyond the headlines to find companies that demonstrate strong fundamentals, adaptability in challenging environments, and potential for long-term value creation.

Top 10 Undiscovered Gems With Strong Fundamentals

NameDebt To EquityRevenue GrowthEarnings GrowthHealth Rating
Etihad Atheeb TelecommunicationNA26.82%62.18%★★★★★★
Ovostar Union0.01%10.19%49.85%★★★★★★
Impellam Group31.12%-5.43%-6.86%★★★★★★
Nofoth Food ProductsNA14.41%31.88%★★★★★★
Industrias del Cobre Sociedad AnónimaNA19.63%22.92%★★★★★★
Tianyun International Holdings10.09%-5.59%-9.92%★★★★★★
Ingersoll-Rand (India)1.05%14.88%27.54%★★★★★☆
A2B Australia15.83%-7.78%25.44%★★★★☆☆
Wilson64.79%30.09%68.29%★★★★☆☆
Waja23.81%98.44%14.54%★★★★☆☆

Click here to see the full list of 4743 stocks from our Undiscovered Gems With Strong Fundamentals screener.

Below we spotlight a couple of our favorites from our exclusive screener.

All Ring Tech (TPEX:6187)

Simply Wall St Value Rating: ★★★★★☆

Overview: All Ring Tech Co., Ltd. specializes in the design, manufacture, and assembly of automation machines in Taiwan and China, with a market capitalization of NT$41.29 billion.

Operations: All Ring Tech generates revenue primarily from its subsidiaries, with All Ring Technology Co., Ltd. contributing NT$2.81 billion and WAN Run Jing Ji Co., Ltd. adding NT$614.98 million to the total revenue stream.

All Ring Tech, a smaller player in the electronics sector, has been making waves with its impressive financial performance. Earnings surged by 137% over the past year, outpacing the industry's 4% growth. The company holds more cash than its total debt, indicating a solid balance sheet. Despite recent shareholder dilution and share price volatility, it remains profitable with positive free cash flow of TWD 111 million as of June 2024. Recent events include a private placement for TWD 1 billion and an equity offering worth TWD 1.39 billion, reflecting strategic moves to bolster capital structure and fuel growth ambitions.

TPEX:6187 Debt to Equity as at Nov 2024

San Fang Chemical Industry (TWSE:1307)

Simply Wall St Value Rating: ★★★★★★

Overview: San Fang Chemical Industry Co., Ltd. specializes in the production and sale of artificial leather, synthetic resin, and other materials across Taiwan, China, Hong Kong, Southeast Asia, and globally with a market capitalization of NT$18.70 billion.

Operations: San Fang Chemical Industry generates revenue primarily through its San Fang Chemical Industry Co., Ltd. segment, contributing NT$7.76 billion, followed by Sanfang Development Co., Ltd. with NT$1.75 billion and PTS at NT$2.44 billion. The company's net profit margin is a key financial metric to consider when evaluating its profitability and cost efficiency within the industry.

San Fang Chemical has shown impressive growth, with earnings surging by 105.8% over the past year, outpacing the Chemicals industry's 15.6%. The company’s net income for Q2 was TWD 299.27 million, up from TWD 188.98 million a year earlier, reflecting robust performance despite a volatile share price recently. Trading at about 53.6% below its estimated fair value suggests potential upside for investors seeking undervalued opportunities in Taiwan's market. Additionally, San Fang boasts high-quality earnings and an appropriate debt level with more cash than total debt, indicating financial stability and sound interest coverage capabilities without concerns over cash runway issues.

TWSE:1307 Debt to Equity as at Nov 2024

Johnson Health Tech .Co (TWSE:1736)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Johnson Health Tech. Co., Ltd. manufactures and sells sports and fitness equipment across the Americas, Europe, Asia, and internationally with a market cap of NT$47.68 billion.

Operations: Johnson Health Tech. Co., Ltd.'s primary revenue streams are derived from Asia, America, and Europe, with Asia contributing NT$36.91 billion and America NT$20.94 billion. The company's financial performance is impacted by adjustments and eliminations totaling -NT$29.15 billion in its revenue calculation.

In the fitness equipment industry, Johnson Health Tech is making waves with recent expansions into Vietnam, establishing two new subsidiaries. Despite a high net debt to equity ratio of 123.1%, the company trades at a significant discount, 41.3% below its estimated fair value. Its earnings have shown impressive growth, surging by 165.3% over the past year—outpacing the leisure industry's -38.1%. For Q2 2024, sales reached TWD 10,307 million compared to TWD 8,636 million last year; however, net income dipped slightly to TWD 292 million from TWD 333 million previously reported.

TWSE:1736 Earnings and Revenue Growth as at Nov 2024

Key Takeaways

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com